Proposed Response Parameters for <scp>Twelve‐Month</scp> Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings

Ivan Foeldvari(Center for Rheumatology), Daniel E. Furst(University of California, Los Angeles), Kathryn S. Torok(University of Pittsburgh Medical Center), Clarissa Pilkington(Great Ormond Street Hospital), Vanessa Smith(Ghent University Hospital), Jordi Antón, Kim Fligelstone(Scleroderma and Raynaud's UK), Maurizio Cutolo(Ospedale Policlinico San Martino), Jens Klotsche(German Rheumatism Research Centre), Patrícia Costa‐Reis(University of Lisbon), Dana Němcová(Charles University), Bernd Hinrichs(Asklepios Fachklinikum Brandenburg), Francesco Del Galdo(University of Leeds), Clare Pain(University of Toronto), Dinesh Khanna(University of Michigan), Suzanne C. Li(Hackensack Meridian Health), Nicolino Ruperto(Istituto Giannina Gaslini), Özgür Kasapçopur(Istituto Giannina Gaslini), Megan L. Curran, Tamás Constantin(Semmelweis University), Anne M. Stevens(Johnson & Johnson (United States)), Christopher P. Denton(The Royal Free Hospital), Alison Zheng(Scleroderma Foundation), Francesca Ingegnoli(University of Milan), Catherine H. Orteu(Royal Free London NHS Foundation Trust), Michael Blakley(Indiana University Health)
Arthritis Care & Research
June 18, 2023
Cited by 10


Related Papers